Research Article
Serum Trace Elements Profile in Graves’ Disease Patients with or without Orbitopathy in Northeast China
Table 5
Bivariate analysis to examine the association between Graves’ ophthalmopathy and trace elements levels.
| | Unadjusted OR (95% CI) | value | Adjusted OR (95% CI) | value |
| Se | 1.058 (0.921–1.214) | 0.426 | 1.117 (0.940–1.328) | 0.210 | V | 1.000 (0.992–1.008) | 0.463 | 1.008 (0.997–1.019) | 0.152 | Fe | 0.996 (0.990–1.001) | 0.110 | 0.992 (0.985–1.000) | 0.051 | Co | 0.963 (0.940–0.987) | 0.003 | 0.963 (0.938–0.988) | 0.004 | Cu | 0.977 (0.961–0.993) | 0.004 | 0.976 (0.958–0.995) | 0.011 | Zn | 0.993 (0.983–1.003) | 0.186 | 1.000 (0.988–1.012) | 0.956 | Rb | 0.996 (0.947–1.047) | 0.874 | 1.004 (0.941–1.070) | 0.910 | Sr | 1.061 (0.831–1.355) | 0.633 | 1.167 (0.876–1.553) | 0.291 | Cs | 0.991 (0.979–1.003) | 0.147 | 0.994 (0.978–1.010) | 0.450 |
|
|
for age, gender, and BMI; Se, selenium; V, vanadium; Fe, iron; Co, cobalt; Cu, copper; Zn, zinc; Rb, rubidium; Sr, strontium; Cs, cesium; OR: odds ratio; 95% CI: 95% confidence interval.
|